People with Parkinson’s are an essential part of the Linked Clinical Trials (LCT) prioritisation meeting. It is important that drug candidates chosen for scientific reasons are also of relevance to people living with Parkinson’s now.  

People with Parkinson’s are a vital resource to help in the design and delivery of clinical trials. We believe that it is time to change perceptions and ensure that people with Parkinson's are considered genuine partners in clinical trials and this is the thinking behind the Parkinson's Movement (PM) development of its Clinical Trials Charter